The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant chemotherapy based on dose-dense epirubicin (E) plus cyclophosphamide (C) followed by docetaxel (D) plus trastuzumab (T), DT plus carboplatin (CBDCA), or DT plus HER2 double blockade in HER2-positive breast cancer patients.
 
Lucia Ceniceros
No Relationships to Disclose
 
Laura Murillo Jaso
No Relationships to Disclose
 
Natalia Rodríguez-Spiteri
No Relationships to Disclose
 
Eduardo Castanon Alvarez
No Relationships to Disclose
 
Leyre Zubiri Oteiza
No Relationships to Disclose
 
Patricia Martin
No Relationships to Disclose
 
Pablo Sala
No Relationships to Disclose
 
Itziar Gardeazabal
No Relationships to Disclose
 
Ignacio Gil-Bazo
No Relationships to Disclose
 
Jaime Espinós
No Relationships to Disclose
 
Jose M. Aramendia
No Relationships to Disclose
 
Oscar Fernández-Hidalgo
No Relationships to Disclose
 
Marta Santisteban
No Relationships to Disclose